Skip to main content

Advertisement

Log in

Vascular Endothelial Growth Factor and Its Type 2 Receptor in Hepatocellular Carcinoma

  • Published:
Bulletin of Experimental Biology and Medicine Aims and scope

Histological analysis demonstrated an increase in the number of blood vessels and expression of CD34 and vascular endothelial growth factor in hepatocellular carcinoma tissue compared to adjacent liver tissue. Increased immunohistochemical expression of vascular endothelial growth factor and the content of this factor and its type 2 receptor correlated with the degree of histological differentiation and stage of the tumor.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. F. Aucejo, R. Kim, N. Zein, et al., Liver Transpl., 15, No. 2, 169-176 (2009).

    Article  PubMed  Google Scholar 

  2. P. Boyle and B. Levin, World Cancer Report 2008, Lyon (2008).

  3. S. V. Brodsky, N. Mendelev, M. Melamed, and G. Ramaswamy, J. Gastrointestin. Liver Dis., 16, No. 4, 373-377 (2007).

    Google Scholar 

  4. R. S. Finn and A. X. Zhu, Expert. Rev. Anticancer Ther., 9, No. 4, 503-509 (2009).

    Article  CAS  PubMed  Google Scholar 

  5. A. O. Kaseb, A. Hanbali, M. Cotant, et al., Cancer, 115, No. 21, 4895-4906 (2009).

    Article  CAS  PubMed  Google Scholar 

  6. D. Marme, World J. Urol., 14, No. 3, 166-174 (1996).

    Article  CAS  PubMed  Google Scholar 

  7. Z. von Marschall, T. Cramer, M. Hocker, et al., Gut, 48, No. 1, 87-96 (2001).

    Article  Google Scholar 

  8. Pathology and Genetics of Tumor of the Digestive System, Eds. S. R. Hamilton and L. A. Aaltonen, Lyon (2000), pp. 159-172.

  9. R. T. Poon, I. O. Ng, C. Lau, et al., Ann. Surg., 233, No. 2, 227-235 (2001).

    Article  CAS  PubMed  Google Scholar 

  10. S. J. Schoenleber, D. M. Kurtz, J. A. Talwalkar, et al., Br. J. Cancer, 100, No. 9, 1385-1392 (2009).

    Article  CAS  PubMed  Google Scholar 

  11. J. H. Shim, J. W. Park, J. H. Kim, et al., Cancer Sci., 99, No. 10, 2037-2044 (2008).

    CAS  PubMed  Google Scholar 

  12. X. Z. Wu, Neoplasma, 55, No. 6, 472-481 (2008).

    CAS  PubMed  Google Scholar 

  13. J. L. Xia, B. H. Yang, Z.Y. Tang, et al., J. Cancer Res. Clin. Oncol., 123, No. 7, 383-387 (1997).

    CAS  PubMed  Google Scholar 

  14. Z. F. Yang and R. T. Poon, Anat. Rec. (Hoboken), 291, No. 6, 721-734 (2008).

    CAS  Google Scholar 

  15. Z. B. Zhang, L. Cai, S. G. Zheng, et al., Pathol. Oncol. Res., 15, No. 3, 495-502 (2009).

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to E. S. Gershtein.

Additional information

Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 149, No. 6, pp. 689-692, June, 2010

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gershtein, E.S., Dubova, E.A., Shchegolev, A.I. et al. Vascular Endothelial Growth Factor and Its Type 2 Receptor in Hepatocellular Carcinoma. Bull Exp Biol Med 149, 749–752 (2010). https://doi.org/10.1007/s10517-010-1043-8

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10517-010-1043-8

Key Words

Navigation